The agency placed 11 foreign firms on import alert and released draft guidance on voluntary U.S.-origin labeling claims for seafood products.
On October 14, 2026, the U.S. Food and Drug Administration (FDA) launched the Rare Disease Framework Initiative (“RDF Initiative”) to develop ...
At the beginning of July 2026, the U.S. Food and Drug Administration approved the first gene therapy for young children with sickle cell disease. While this is good news for children in the U.S. born ...
In a new draft guidance, the US Food and Drug Administration (FDA) has provided details on the clinical investigation requirements that sponsors of new drugs must meet to obtain three years of ...
At the beginning of July 2026, the U.S. Food and Drug Administration approved the first gene therapy for young children with sickle cell disease. While this is good news for children in the U.S. born ...